Literature DB >> 24961649

Poly-lysine peptidomimetics having potent antimicrobial activity without hemolytic activity.

Mija Ahn1, Binu Jacob, Pethaiah Gunasekaran, Ravichandran N Murugan, Eun Kyoung Ryu, Ga-hyang Lee, Jae-Kyung Hyun, Chaejoon Cheong, Nam-Hyung Kim, Song Yub Shin, Jeong Kyu Bang.   

Abstract

Diversity of sequence and structure in naturally occurring antimicrobial peptides (AMPs) limits their intensive structure-activity relationship (SAR) study. In contrast, peptidomimetics have several advantages compared to naturally occurring peptide in terms of simple structure, convenient to analog synthesis, rapid elucidation of optimal physiochemical properties and low-cost synthesis. In search of short antimicrobial peptides using peptidomimetics, which provide facile access to identify the key factors involving in the destruction of pathogens through SAR study, a series of simple and short peptidomimetics consisting of multi-Lys residues and lipophilic moiety have been prepared and found to be active against several Gram-negative and Gram-positive bacteria containing methicillin-resistant Staphylococcus aureus (MRSA) without hemolytic activity. Based on the SAR studies, we found that hydrophobicity, +5 charges of multiple Lys residues, hydrocarbon tail lengths and cyclohexyl group were crucial for antimicrobial activity. Furthermore, membrane depolarization, dye leakage, inner membrane permeability and time-killing kinetics revealed that bacterial-killing mechanism of our peptidomimetics is different from the membrane-targeting AMPs (e. g. melittin and SMAP-29) and implied our peptidomimetics might kill bacteria via the intracellular-targeting mechanism as done by buforin-2.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24961649     DOI: 10.1007/s00726-014-1778-z

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  7 in total

Review 1.  Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs.

Authors:  Natalia Molchanova; Paul R Hansen; Henrik Franzyk
Journal:  Molecules       Date:  2017-08-29       Impact factor: 4.411

Review 2.  Peptides and Peptidomimetics for Antimicrobial Drug Design.

Authors:  Biljana Mojsoska; Håvard Jenssen
Journal:  Pharmaceuticals (Basel)       Date:  2015-07-13

3.  Cationic Amphipathic Triazines with Potent Anti-bacterial, Anti-inflammatory and Anti-atopic Dermatitis Properties.

Authors:  Pethaiah Gunasekaran; Ganesan Rajasekaran; Eun Hee Han; Young-Ho Chung; Young-Jin Choi; Yu Jin Yang; Ji Eun Lee; Hak Nam Kim; Kiram Lee; Jin-Seok Kim; Hyun-Jun Lee; Eun-Ju Choi; Eun-Kyung Kim; Song Yub Shin; Jeong Kyu Bang
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

4.  Synthesis of Fmoc-Triazine Amino Acids and Its Application in the Synthesis of Short Antibacterial Peptidomimetics.

Authors:  Pethaiah Gunasekaran; Eun Young Kim; Jian Lee; Eun Kyoung Ryu; Song Yub Shin; Jeong Kyu Bang
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

5.  Amphiphilic Triazine Polymer Derivatives as Antibacterial And Anti-atopic Agents in Mice Model.

Authors:  Pethaiah Gunasekaran; Meiqi Fan; Eun Young Kim; Jun Ho Shin; Ji Eun Lee; Eun Ju Son; Jaehi Kim; Eunha Hwang; Min Su Yim; Eun-Hee Kim; Young-Jin Choi; Young-Ho Lee; Young-Ho Chung; Hak Nam Kim; Eun Kyoung Ryu; Song Yub Shin; Eun-Kyung Kim; Jeong Kyu Bang
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

Review 6.  Emerging Nanomedicine Therapies to Counter the Rise of Methicillin-Resistant Staphylococcus aureus.

Authors:  Alan Hibbitts; Cian O'Leary
Journal:  Materials (Basel)       Date:  2018-02-23       Impact factor: 3.623

Review 7.  The Continuing Threat of Methicillin-Resistant Staphylococcus aureus.

Authors:  Márió Gajdács
Journal:  Antibiotics (Basel)       Date:  2019-05-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.